Francis Crick Institute

Francis Crick Institute
Name	Francis Crick Institute
Established	2015
Founder	Paul Nurse, Tim Hunt, John Skehel
Type	Biomedical research institute
President	Paul Nurse
Director	John Diffley
City	London
Country	United Kingdom
Address	1 Midland Road, London
Affiliations	Medical Research Council (UK), Cancer Research UK, Wellcome Trust, University College London, Imperial College London, King's College London
Website	crick.ac.uk

Francis Crick Institute. It is a major biomedical discovery institute located in the King's Cross area of London, formed through a unique partnership of six founding organizations. The institute's mission is to conduct discovery research to understand why disease develops and to pioneer new treatments, diagnostics, and technologies. Named after the co-discoverer of the structure of DNA, Francis Crick, it is one of the largest single biomedical laboratories in Europe.

History and establishment

The concept for a new, consolidated center for biomedical research in London was first proposed in the early 2000s, championed by scientists including Paul Nurse and Tim Hunt. A key milestone was the 2007 publication of the "UK Centre for Medical Research and Innovation" proposal, which gained formal backing from the UK Government in 2010. The project brought together three major research funders—the Medical Research Council (UK), Cancer Research UK, and the Wellcome Trust—with three leading academic partners: University College London, Imperial College London, and King's College London. Construction of the distinctive building, designed by the architectural firm HOK and PLP Architecture, began in 2011 on the site of the former British Library newspaper depository. The institute was officially opened in 2016 by Queen Elizabeth II, with its first researchers having moved in the previous year.

Research and scientific focus

Research is organized around interdisciplinary programs rather than traditional departments, focusing on the fundamental biology underlying human health. Major areas of investigation include the mechanisms of cancer, the function of the immune system, the development of the nervous system, and the processes of infection and parasitism. Scientists employ a wide range of techniques, from structural biology and genomics to advanced imaging and computational biology. The institute places a strong emphasis on translating basic discoveries into clinical applications, with work spanning early-stage biology to potential new therapies and diagnostic tools for conditions like malaria, tuberculosis, and COVID-19.

Facilities and infrastructure

The institute occupies a striking 170,000 square meter building, notable for its distinctive "brise soleil" facade and large public atrium. It houses over 1,500 scientists and staff across 12 floors, containing more than 1,600 laboratory modules designed for flexibility. State-of-the-art facilities include the MRC London Institute of Medical Sciences equipment, high-containment laboratories for studying dangerous pathogens, and the Advanced Sequencing Facility. The building also features a public exhibition space named the "Discovery Centre," an auditorium, and numerous collaborative spaces intended to foster interactions between research groups from different disciplines.

Governance and funding

The institute operates as an independent charitable body, governed by a board of trustees drawn from its founding partners and the wider scientific community. Its president is Paul Nurse, a Nobel laureate and former president of the Royal Society. Day-to-day scientific leadership is provided by the executive director, a role held by John Diffley since 2022. Core funding is provided through a long-term commitment from the three founding charitable funders, with additional support coming from competitive grants from bodies like the European Research Council and BBSRC, as well as philanthropic donations and commercial partnerships.

Collaborations and partnerships

Beyond its six founding partners, the institute maintains extensive collaborative networks with research institutions worldwide. It has formal strategic alliances with organizations such as the Howard Hughes Medical Institute in the United States and the Centre for Genomic Regulation in Barcelona. It works closely with the nearby Great Ormond Street Hospital for children and the University College London Hospitals NHS Foundation Trust to facilitate clinical research. The institute also engages in numerous international consortia, such as the Human Cell Atlas project, and partners with pharmaceutical companies including GlaxoSmithKline and AstraZeneca on specific research programs.

Notable achievements and discoveries

Since its opening, scientists have made significant contributions across several fields. Researchers played a key role in the early genomic sequencing of the SARS-CoV-2 virus during the COVID-19 pandemic in the United Kingdom. Teams have published groundbreaking work on the mechanisms of DNA replication and repair, the development of the embryo, and the behavior of T cells in cancer. The institute's work has led to the development of new experimental models for studying human disease and has provided fundamental insights into the biology of pathogens like Plasmodium falciparum, the parasite that causes the most severe form of malaria.

Category:Biomedical research institutes Category:Research institutes in London Category:Organizations established in 2015